Search research articles
Contact Us
Filters
Showing results (171-180 of 289) with videos related to
Page
of 29
Sort By:
Translational Psychiatry
|
February 6, 2019
Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging
Alessandra Griffa, Philipp S Baumann, Paul Klauser, et al.
Schizophrenia (Heidelberg, Germany)
|
May 15, 2025
Pathways between childhood trauma, clinical symptoms, and functioning in new-onset psychosis: novel insights from a network analysis approach
Dimitrios Kiakos, Luis Alameda, Ines Lepreux, et al.
The Journal of Clinical Psychiatry
|
May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study
Marianna Piras, Céline Dubath, Mehdi Gholam, et al.
Revue Medicale Suisse
|
September 22, 2021
[PsyYoung: A transcantonal project for facilitating access to care for young people at risk for psychotic disorders]
Christina Andreou, Barbara Bailey, Marco Armando, et al.
The Journal of Clinical Psychiatry
|
March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort Study
Claire Grosu, William Hatoum, Marianna Piras, et al.
Schizophrenia Bulletin
|
April 6, 2021
Fronto-Temporal Disconnection Within the Presence Hallucination Network in Psychotic Patients With Passivity Experiences
Giedre Stripeikyte, Jevita Potheegadoo, Pierre Progin, et al.
Clinical Epigenetics
|
February 28, 2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study
Céline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.
Therapeutic Drug Monitoring
|
June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients
Nicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Frontiers in Psychiatry
|
February 28, 2024
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients
Nermine Laaboub, Isabella Locatelli, Claire Grosu, et al.
Psychopharmacology
|
October 28, 2017
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Silvia Rigucci, Lijing Xin, Paul Klauser, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 289) with videos related to
Sort By:
Page
of 29
Translational Psychiatry
|
February 6, 2019
Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging
Alessandra Griffa, Philipp S Baumann, Paul Klauser, et al.
Schizophrenia (Heidelberg, Germany)
|
May 15, 2025
Pathways between childhood trauma, clinical symptoms, and functioning in new-onset psychosis: novel insights from a network analysis approach
Dimitrios Kiakos, Luis Alameda, Ines Lepreux, et al.
The Journal of Clinical Psychiatry
|
May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study
Marianna Piras, Céline Dubath, Mehdi Gholam, et al.
Revue Medicale Suisse
|
September 22, 2021
[PsyYoung: A transcantonal project for facilitating access to care for young people at risk for psychotic disorders]
Christina Andreou, Barbara Bailey, Marco Armando, et al.
The Journal of Clinical Psychiatry
|
March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort Study
Claire Grosu, William Hatoum, Marianna Piras, et al.
Schizophrenia Bulletin
|
April 6, 2021
Fronto-Temporal Disconnection Within the Presence Hallucination Network in Psychotic Patients With Passivity Experiences
Giedre Stripeikyte, Jevita Potheegadoo, Pierre Progin, et al.
Clinical Epigenetics
|
February 28, 2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study
Céline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.
Therapeutic Drug Monitoring
|
June 4, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients
Nicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar, et al.
Frontiers in Psychiatry
|
February 28, 2024
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients
Nermine Laaboub, Isabella Locatelli, Claire Grosu, et al.
Psychopharmacology
|
October 28, 2017
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Silvia Rigucci, Lijing Xin, Paul Klauser, et al.
Page
of 29